Merck KGaA : Healthcare and Electronics to drive 2024, Life Sciences to turn around
>Solid start into the year, Healthcare and Electronics to drive 2024 - The first quarter was a good start into the year for Merck on the back of a strong Healthcare performance as well as Electronics ahead of expectations. The quantitative guidance for 2024 looks solid on the top line with 1% to 5% organic sales growth (ODDO BHF 3.3%) and an EBITDA pre of € 5.7bn to € 6.3bn (ODDO BHF € 6.0bn). The most relevant driver for the share price will be better visibility on t...Merck is a global science and technology company based in Germany. Co. diversifies its activities into four business divisions: Merck Serono, Consumer Health, Performance Materials and Merck Millipore. The Merck Serono develops, manufactures and markets prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and selected cardiovascular and metabolic diseases. The Consumer Health manufactures and markets over-the-counter drugs addressing health themes such as mobility, women's and children's health, cough and cold. Performance Materials is a specialty chemicals business. The Merck Millipore is the supplier of products and services for the life science industry.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.